{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"iminoglycinuria","columns":[{"gene":"","key":"population-e2f0043401625861dcee","label":"IMINOGLYCINURIA","mondoId":"MONDO:0009448","onsetQualifier":null,"originColumnKey":"MONDO:0009448/OMIM:242600","originalViews":[{"key":"MONDO:0009448/OMIM:242600","label":"IMINOGLYCINURIA","scopeLabel":"OMIM:242600","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["5035c107d03bf2d8a4ad80d83cb60d177c2ddc8968c83342a0eda2820d46c854","77d6ab9bdbc42524adabf9481ff93bfe3bf17162ea1f8fbd2186cd060479d213","8d01991a6488600071bb276d4daea43f2a7c6580f2260a4d40dcd0dc0730394a","d60416d8ab8581b9ece78ffcc4b5480c921968e4b682962ab5643cd30b69706b","ef9707fd4e30e50cbcba063e57224bdd13733be8d522672439cb3ec8a2add247"],"recordQualifiers":{},"scopeLabel":"OMIM:242600","sourceIds":["OMIM:242600"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-e64490f7845fbf4486dd","label":"Iminoglycinuria","mondoId":"MONDO:0009448","onsetQualifier":null,"originColumnKey":"MONDO:0009448/ORPHA:42062","originalViews":[{"key":"MONDO:0009448/ORPHA:42062","label":"Iminoglycinuria","scopeLabel":"ORPHA:42062","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["9b153422e2a733d7e9bd3e9e4daa2ebdf1cc7fe7a7d9949c5a989488d5c63734","bb6778924f1a45514f09ca3f8e0db438480b272dbb0a987b850f7ea490415bec","bc086d59e2fb60113816eaeec1270bf7609dc9d6a82da3c814739793ce07d53c","c97108bf34374a20ebe0669a1f2652b580a67ee4340b52d2f948f96a870ec49e","ec9b5002d68a3da87f4eddb8b08c0da634bea563dc4abfba5fce94ebe8ec11ee","ffe74567923e98054e4e2386cfedb54bfd6ef77fa0357464ed552a5d8dcea52d"],"recordQualifiers":{},"scopeLabel":"ORPHA:42062","sourceIds":["ORPHA:42062"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e2f0043401625861dcee","population-e64490f7845fbf4486dd"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000478","HP:0003260","HP:0003080","HP:0002154","HP:0003108","HP:0008358","HP:0001249"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":5,"orphanet":6}},"features":[{"hpoId":"HP:0000478","label":"Abnormality of the eye","primary":true},{"hpoId":"HP:0003260","label":"Hydroxyprolinemia","primary":true},{"hpoId":"HP:0003080","label":"Hydroxyprolinuria","primary":true},{"hpoId":"HP:0002154","label":"Hyperglycinemia","primary":true},{"hpoId":"HP:0003108","label":"Hyperglycinuria","primary":true},{"hpoId":"HP:0008358","label":"Hyperprolinemia","primary":true},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":true},{"hpoId":"HP:0003137","label":"Prolinuria","primary":false}],"ledeHtml":"A rare inborn error of metabolism characterized by elevated levels of imino acids (proline, hydroxyproline) and glycine in urine due to defective reabsorption in the kidney. The condition is considered benign and not associated with any specific clinical phenotype. Mode of inheritance is autosomal recessive.","mondoId":"MONDO:0009448","node":{"canonicalSlug":"iminoglycinuria","comparisons":[{"documentSha256":"6442b7cc42212c5ab145a88bfda3e73cb318b15cb400e045036465407c531807","key":"legacy-iminoglycinuria","kind":"legacy","label":"iminoglycinuria","memberIds":["MONDO:0009448"],"mondoId":"MONDO:0009448","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/iminoglycinuria.6442b7cc42212c5ab145a88bfda3e73cb318b15cb400e045036465407c531807.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Iminoglycinuria","originalSourceId":"ORPHA:42062","paragraphs":["A rare inborn error of metabolism characterized by elevated levels of imino acids (proline, hydroxyproline) and glycine in urine due to defective reabsorption in the kidney. The condition is considered benign and not associated with any specific clinical phenotype. Mode of inheritance is autosomal recessive."],"rawAttribution":"MONDO:0009448","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:17Z","upstream":"MONDO:0009448","url":"https://rarediseases.info.nih.gov/diseases/8424"},"ownColumnKeys":["population-e2f0043401625861dcee","population-e64490f7845fbf4486dd"],"publication":"published","relationships":[{"kind":"parent","label":"inborn disorder of amino acid transport","mondoId":"MONDO:0019216","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"5035c107d03bf2d8a4ad80d83cb60d177c2ddc8968c83342a0eda2820d46c854","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:242600","disease_name":"IMINOGLYCINURIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003080","is_excluded":false,"label":"Hydroxyprolinuria","onset_id":null,"reference":"OMIM:242600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"77d6ab9bdbc42524adabf9481ff93bfe3bf17162ea1f8fbd2186cd060479d213","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:242600","disease_name":"IMINOGLYCINURIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003137","is_excluded":false,"label":"Prolinuria","onset_id":null,"reference":"OMIM:242600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8d01991a6488600071bb276d4daea43f2a7c6580f2260a4d40dcd0dc0730394a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:242600","disease_name":"IMINOGLYCINURIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:242600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9b153422e2a733d7e9bd3e9e4daa2ebdf1cc7fe7a7d9949c5a989488d5c63734","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:42062","disease_name":"Iminoglycinuria","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0003108","is_excluded":false,"label":"Hyperglycinuria","onset_id":null,"reference":"ORPHA:42062","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bb6778924f1a45514f09ca3f8e0db438480b272dbb0a987b850f7ea490415bec","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:42062","disease_name":"Iminoglycinuria","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0003137","is_excluded":false,"label":"Prolinuria","onset_id":null,"reference":"ORPHA:42062","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc086d59e2fb60113816eaeec1270bf7609dc9d6a82da3c814739793ce07d53c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:42062","disease_name":"Iminoglycinuria","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0003080","is_excluded":false,"label":"Hydroxyprolinuria","onset_id":null,"reference":"ORPHA:42062","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c97108bf34374a20ebe0669a1f2652b580a67ee4340b52d2f948f96a870ec49e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:42062","disease_name":"Iminoglycinuria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003260","is_excluded":true,"label":"Hydroxyprolinemia","onset_id":null,"reference":"ORPHA:42062","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d60416d8ab8581b9ece78ffcc4b5480c921968e4b682962ab5643cd30b69706b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:242600","disease_name":"IMINOGLYCINURIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003108","is_excluded":false,"label":"Hyperglycinuria","onset_id":null,"reference":"OMIM:242600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ec9b5002d68a3da87f4eddb8b08c0da634bea563dc4abfba5fce94ebe8ec11ee","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:42062","disease_name":"Iminoglycinuria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008358","is_excluded":true,"label":"Hyperprolinemia","onset_id":null,"reference":"ORPHA:42062","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ef9707fd4e30e50cbcba063e57224bdd13733be8d522672439cb3ec8a2add247","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:242600","disease_name":"IMINOGLYCINURIA","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000478","is_excluded":false,"label":"Abnormality of the eye","onset_id":null,"reference":"OMIM:242600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ffe74567923e98054e4e2386cfedb54bfd6ef77fa0357464ed552a5d8dcea52d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:42062","disease_name":"Iminoglycinuria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002154","is_excluded":true,"label":"Hyperglycinemia","onset_id":null,"reference":"ORPHA:42062","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8424\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009448\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0009448</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare inborn error of metabolism characterized by elevated levels of imino acids (proline, hydroxyproline) and glycine in urine due to defective reabsorption in the kidney. The condition is considered benign and not associated with any specific clinical phenotype. Mode of inheritance is autosomal recessive.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8424\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"iminoglycinuria","sourceDocuments":[{"name":"GARD: Iminoglycinuria","reviewed":null,"source_release":"2026-10-21T17:06:17Z","url":"https://rarediseases.info.nih.gov/diseases/8424"},{"name":"MONDO: iminoglycinuria","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009448"}],"sourceNote":"","synonyms":["iminoglycinuria","iminoglycinuria, digenic"],"takeawayHtml":"","title":"iminoglycinuria"},"schemaVersion":1}
